192 related articles for article (PubMed ID: 23982174)
1. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
Pidala J; Wang T; Haagenson M; Spellman SR; Askar M; Battiwalla M; Baxter-Lowe LA; Bitan M; Fernandez-Viña M; Gandhi M; Jakubowski AA; Maiers M; Marino SR; Marsh SG; Oudshoorn M; Palmer J; Prasad VK; Reddy V; Ringden O; Saber W; Santarone S; Schultz KR; Setterholm M; Trachtenberg E; Turner EV; Woolfrey AE; Lee SJ; Anasetti C
Blood; 2013 Nov; 122(22):3651-8. PubMed ID: 23982174
[TBL] [Abstract][Full Text] [Related]
2. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
3. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
4. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
Carapito R; Jung N; Kwemou M; Untrau M; Michel S; Pichot A; Giacometti G; Macquin C; Ilias W; Morlon A; Kotova I; Apostolova P; Schmitt-Graeff A; Cesbron A; Gagne K; Oudshoorn M; van der Holt B; Labalette M; Spierings E; Picard C; Loiseau P; Tamouza R; Toubert A; Parissiadis A; Dubois V; Lafarge X; Maumy-Bertrand M; Bertrand F; Vago L; Ciceri F; Paillard C; Querol S; Sierra J; Fleischhauer K; Nagler A; Labopin M; Inoko H; von dem Borne PA; Kuball J; Ota M; Katsuyama Y; Michallet M; Lioure B; Peffault de Latour R; Blaise D; Cornelissen JJ; Yakoub-Agha I; Claas F; Moreau P; Milpied N; Charron D; Mohty M; Zeiser R; Socié G; Bahram S
Blood; 2016 Oct; 128(15):1979-1986. PubMed ID: 27549307
[TBL] [Abstract][Full Text] [Related]
5. Impact of amino acid substitution at residue 9 of HLA-A2 on the development of acute GVHD in Korean pediatric patients receiving unrelated hematopoietic stem cell transplantation.
Hwang SH; Oh HB; Choi SE; Seo JJ; Lee JH; Cho SW; Chae JM; Heo YS; Chang CL; Lee EY
Transpl Int; 2010 Dec; 23(12):1216-22. PubMed ID: 20536911
[TBL] [Abstract][Full Text] [Related]
6. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
7. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Nowak J; Nestorowicz K; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Jaskula E; Koscinska K; Madej S; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Halaburda K; Dybko J; Kuliczkowski K; Czerw T; Giebel S; Holowiecki J; Baranska M; Pieczonka A; Wachowiak J; Czyz A; Gil L; Lojko-Dankowska A; Komarnicki M; Bieniaszewska M; Kucharska A; Hellmann A; Gronkowska A; Jedrzejczak WW; Markiewicz M; Koclega A; Kyrcz-Krzemien S; Mielcarek M; Kalwak K; Styczynski J; Wysocki M; Drabko K; Wojcik B; Kowalczyk J; Gozdzik J; Pawliczak D; Gwozdowicz S; Dziopa J; Szlendak U; Witkowska A; Zubala M; Gawron A; Warzocha K; Lange A
Hum Immunol; 2018 Jun; 79(6):403-412. PubMed ID: 29605688
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
9. Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm.
Littera R; Orrù N; Caocci G; Sanna M; Mulargia M; Piras E; Vacca A; Giardini C; Orofino MG; Visani G; Bertaina A; Giorgiani G; Locatelli F; Carcassi C; La Nasa G
Br J Haematol; 2012 Jan; 156(1):118-28. PubMed ID: 22077388
[TBL] [Abstract][Full Text] [Related]
10. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
Wu X; Yao Y; Bao X; Zhou H; Tang X; Han Y; Ma X; Liu Y; Chen J; Zhou H; Jing S; Gu B; Xu Y; Sun A; He J; Wu D
Biol Blood Marrow Transplant; 2016 Feb; 22(2):220-225. PubMed ID: 26476204
[TBL] [Abstract][Full Text] [Related]
11. Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation.
Hosokai R; Masuko M; Shibasaki Y; Saitoh A; Furukawa T; Imai C
Biol Blood Marrow Transplant; 2017 Apr; 23(4):606-611. PubMed ID: 28042021
[TBL] [Abstract][Full Text] [Related]
12. Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation.
Graczyk-Pol E; Rogatko-Koros M; Nestorowicz K; Gwozdowicz S; Mika-Witkowska R; Pawliczak D; Zubala M; Szlendak U; Witkowska A; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Wojcik M; Halaburda K; Nowak J
HLA; 2018 Dec; 92 Suppl 2():42-46. PubMed ID: 30168290
[TBL] [Abstract][Full Text] [Related]
13. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
Cooley S; Trachtenberg E; Bergemann TL; Saeteurn K; Klein J; Le CT; Marsh SG; Guethlein LA; Parham P; Miller JS; Weisdorf DJ
Blood; 2009 Jan; 113(3):726-32. PubMed ID: 18945962
[TBL] [Abstract][Full Text] [Related]
14. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing.
Giebel S; Giorgiani G; Martinetti M; Zecca M; Maccario R; Salvaneschi L; Holowiecki J; Locatelli F
Bone Marrow Transplant; 2003 Jun; 31(11):987-93. PubMed ID: 12774049
[TBL] [Abstract][Full Text] [Related]
17. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
18. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
[TBL] [Abstract][Full Text] [Related]
19. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
20. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
